The Bronx, NY2 Active Studies

Advanced Solid Tumors Clinical Trials in The Bronx, NY

Find 2 actively recruiting advanced solid tumors clinical trials in The Bronx, NY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
146
Enrolling

Recruiting Advanced Solid Tumors Studies in The Bronx

About Advanced Solid Tumors Clinical Trials in The Bronx

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 2 advanced solid tumors clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 146 participants. Research is being sponsored by Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in The Bronx — FAQ

Are there advanced solid tumors clinical trials in The Bronx?

Yes, there are 2 advanced solid tumors clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 2 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov